FDA Drug Recalls

Recalls / Class II

Class IID-0417-2020

Product

ActivEyes Altachlore Solution, 15 mL (1/2 FL OZ), Manufactured by Altaire Pharmaceuticals Inc., Aquebogue, NY 11931, NDC 59390-183-13

Brand name
Altachlore Sodium Chloride Hypertonicity
Generic name
Sodium Chloride
Active ingredient
Sodium Chloride
Route
Ophthalmic
NDC
59390-183
FDA application
M018
Affected lot / code info
18008 1/20 8/13/2018 19050 2/22 3/18/2019 19105 4/22

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Altaire Pharmaceuticals, Inc.
Manufacturer
Altaire Pharmaceuticals Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
311 W Ln, PO Box 849, Aquebogue, New York 11931-0849

Distribution

Quantity
22494 units
Distribution pattern
U.S.A. Nationwide

Timeline

Recall initiated
2019-07-02
FDA classified
2019-11-15
Posted by FDA
2019-11-27
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0417-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Altachlore Sodium Chloride Hypertonicity · FDA Drug Recalls